DSC00262

Clinical trials of a new scheme for treating patients with drug-sensitive and chemo-resistant tuberculosis: next steps

On 1-3 July 2015, the working meetings took place with phthsiologists (TB doctors) from Kyiv, Kyiv Oblast and Chernigiv Oblast where new steps were discussed in Ukraine’s participation in clinical trials of a new scheme for treating patients with drug-resistant and chemoresistant TB. TBEC earlier reported that Ukraine has started clinical trials of Pretomanid.

The clinical trials were initiated by an international organisation – the Global Alliance for TB Drug Development (TB Alliance).

In Ukraine, clinical trials are being conducted by F.G. Yanovsky National Phthisiology and Pulmonology Institute of the National Academy of Medical Sciences of Ukraine with informational support provided by “Ukrainians Against TB” Public Movement” Foundation.

As part of the project’s implementation, working meetings had been arranged in Kyiv, Kyiv Oblast and Chernigiv Oblast. The meetings were held:

On 1 July – with Kyiv phthisiologists – at F.G. Yanovsky National Phthisiology and Pulmonology Institute of the National Academy of Medical Sciences of Ukraine;

On 2 July – with Kyiv Oblast phthisiologists – at Kyiv Oblast Tuberculosis Hospital;

On 3 July – with Chernigiv Oblast phthisiologists – at Chernigiv Oblast Tuberculosis Hospital.

Overall, more than 90 phthisiologists took part in the meetings.

The following persons addressed the participants of the working meetings:

– head of the chemoresistant TB division of F.G. Yanovsky National Phthisiology and Pulmonology Institute of the National Academy of Medical Sciences of Ukraine Svitlana Cherenko, doctor of medical sciences, professor;

– senior researcher of F.G. Yanovsky National Phthisiology and Pulmonology Institute of the National Academy of Medical Sciences of Ukraine Nataliya Lytvynenko, candidate of medical sciences;

– chairman of the board of “Health Without Borders” International Journalist Association, member of the National Council to Control TB and HIV/AIDS Igor Gorbasenko, candidate of psychological sciences;

– chairman of the board of “Ukrainians Against TB” Public Movement” Foundation Vitaly Rudenko.

Participants in the meetings discussed practical issues regarding the launch of clinical trials of a new scheme for treating patients with drug-sensitive and chemo-resistant TB, criteria for and ways of involving patients in them.

This information was received come from the Coalition partners in Ukraine, “Ukrainians Against TB” Public Movement” Foundation (contact person – Vitalii Rudenko, chairman of the board, E-mail: stoptb@ukr.net
www.stoptb.org.ua)


This blog is the product of an activity that has received funding under an
operating grant from the European Union’s Health Programme (2014-2020).
The content of this blog represents the views of the author only and is
his/her sole responsibility; it cannot be considered to reflect the views
of the EuropeanCommission and/or the Consumers, Health, Agriculture and
Food Executive Agency or any other body of the European Union. The European
Commission and the Agency do not accept any responsibility for use that
may be made of the information it contains.
flag_yellow_low